Long-term disease surveillance in Bandundu region, Democratic Republic of the Congo: A model for early detection and prevention of Ebola hemorrhagic fever

Journal of Infectious Diseases

Volumn 179, Issue SUPPL. 1, 1999, Pages

  Lloyd, Ethleen S ^a,b,c,d,e   Zaki, Sherif R ^a,b,c,d,e   Rollin, Pierre E ^a,b,c,d,e   Tshioko, Kweteminga ^a,b,c,d,e   Bwaka, Mpia A ^a,b,c,d,e,g   Ksiazek, Thomas G ^a,b,c,d,e   Calain, Philippe ^a,b,c,d,e   Shieh, Wun Ju ^a,b,c,d,e   Kondé, M Kader ^a,b,c,d,e   Verchueren, Eric ^{a,b,c,d,e,f,g}   Perry, Helen N ^a,b,c,d,e   Manguindula, Lubaki ^a,b,c,d,e   Kabwau, Jean ^{a,b,c,d,e,f,g,h}   Ndambi, Roger ^a,b,c,d,e   Peters, C J ^a,b,c,d,e  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b W H O/US A for I D/M of H ^*  (Democratic Republic Congo)

^c Hosp Gen de Reference de Kikwit   (Democratic Republic Congo)

^d Mosango Mission Hospital   (Democratic Republic Congo)

^e MÉDECINS SANS FRONTIÈRES   (Belgium)

^f NATL CENTER FOR INFECTIOUS DISEASES   (United States)

^g INSTITUTE OF TROPICAL MEDICINE   (Belgium)

^h WORLD HEALTH ORGANIZATION   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

AFRICA; CLINICAL PRACTICE; CONFERENCE PAPER; DIAGNOSTIC TEST; EARLY DIAGNOSIS; EBOLA VIRUS; FOLLOW UP; HISTOCHEMISTRY; IMMUNOHISTOCHEMISTRY; NURSING; PRIORITY JOURNAL; VIRUS HEMORRHAGIC FEVER; VIRUS ISOLATION; WORLD HEALTH ORGANIZATION;

EID: 0033062221     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/514312     Document Type: Conference Paper

References (33)

1. 1. Muyembe T, Kipasa M, International Scientific and Technical Committee, WHO Collaborating Centre for Haemorrhagic Fevers. Ebola haemorrhagic fever in Kikwit, Zaire [letter]. Lancet 1995;345:1448.
2. 2. Khan AS, Tshioko FK, Heymann DL, et al. The reemergence of Ebola hemorrhagic fever, Democratic Republic of the Congo, 1995. J Infect Dis 1999; 179(suppl 1):S76-86.
3. 3. Zaki SR, Greer PW, Goldsmith CS, et al. Ebola virus hemorrhagic fever: pathologic, immunopathologic and ultrastructural study [abstract]. Lab Invest 1996; 74:133A.
4. 4. Zaki SR, Shieh WJ, Greer PW, et al. A novel immunohistochemical assay for detection of Ebola virus in skin: implications for diagnosis, spread, and surveillance of Ebola hemorrhagic fever. J Infect Dis 1999; 179(suppl 1):S36-47.
5. 5. International Commission. Ebola haemorrhagic fever in Zaire, 1976. Bull WHO 1978;56:271-93.
6. 6. WHO/International Study Team. Ebola haemorrhagic fever in Sudan, 1976. Bull WHO 1978,56:247-70.
7. 7. Baron RC, McCormick JB, Zubeir OA. Ebola virus disease in southern Sudan: hospital dissemination and intrafamilial spread. Bull WHO 1983; 61:997-1003.
8. 8. Dowell SF, Mukunu R, Ksiazek TG, et al. Transmission of Ebola hemorrhagic fever: a study of risk factors in family members, Kikwit, Democratic Republic of the Congo, 1995. J Infect Dis 1999; 179(suppl 1): S87-91.
9. 9. Busico KM, Marshall KL, Ksiazek TG, et al. Prevalence of IgG antibodies to Ebola virus in individuals during an Ebola outbreak, Democratic Republic of the Congo, 1995. J Infect Dis 1999; 179(suppl 1):S102-7.
10. 10. Heymann DL, Weisfeld JS, Webb PA, et al. Ebola hemorrhagic fever: Tandala, Zaire, 1977 - 1978. J Infect Dis 1980; 142:372-6.
11. 11. Jezek Z, Szczeniowski MY, Muyembe-Tamfum JJ, McCormick JB, Heymann DL. Ebola between outbreaks: intensified Ebola hemorrhagic fever surveillance in the Democratic Republic of the Congo, 1981 - 1985. J Infect Dis 1999; 179(suppl 1):S60-4.
12. 12. Ksiazek TG, Rollin PE, Williams AJ, et al. Clinical virology of Ebola hemorrhagic fever (EHF): virus, virus antigen, and IgG and IgM antibody findings among EHF patients in Kikwit, Democratic Republic of the Congo, 1995. J Infect Dis 1999; 179(suppl 1):S177-87.
13. 13. Van der Groen G, Johnson KM, Webb PA, et al. Results of Ebola antibody surveys in various population groups. In: Pattyn SR, ed. Ebola virus haemonhagic fever. Amsterdam: Elsevier/North-Holland Biomedical Press, 1978.
14. 14. Georges-Courbot MC, Sanchez A, Lu CY, et al. Isolation and phylogenetic characterization of Ebola viruses causing different outbreaks in Gabon. Emerg Infect Dis 1997;3:59-62.
15. 15. Formenty P, Hatz C, Le Guenno B, Stoll A, Rogenmoser P, Widmer A. Human infection due to Ebola virus, subtype Côte d'lvoire: clinical and biologic presentation. J Infect Dis 1999; 179(suppl 1):S48-53.
16. 16. Kerstiëns B, Matthys F. Interventions to control transmission during an outbreak of Ebola hemorrhagic fever: experience from Kikwit, Democratic Republic of the Congo, 1995. J Infect Dis 1999; 179(suppl 1): S63-7.
17. 17. Bwaka MA, Bonnet MJ, Calain P, et al. Ebola hemorrhagic fever in Kikwit, Democratic Republic of the Congo: clinical observations in 103 patients. J Infect Dis 1999; 179(suppl 1):S1-7.
18. 18. Muyembe-Tamfum JJ, Kipasa M, Kiyungu C, Colebunders R. Ebola outbreak in Kikwit, Democratic Republic of the Congo: discovery and control measures. J Infect Dis 1999; 179(suppl 1):S259-62.
19. 19. Centers for Disease Control and Prevention. Management of patients with suspected viral hemorrhagic fever. MMWR Morb Mortal Wkly Rep 1988:37(suppl 3)1-16.
20. 20. Centers for Disease Control and Prevention. Update: management of patients with suspected viral hemorrhagic fever - United States. MMWR Morb Mortal Weekly Rep 1995;44:475-9.
21. 21. World Health Organization. Procedures for the surveillance and management of monkeypox and viral haemorrhagic fevers (yellow fever, Lassa fever, Ebola and Marburg virus diseases). In: Seminar on the Surveillance of Monkeypox and Viral Haemorrhagic Fevers (28 April 1980). Brazzaville, Congo: WHO Regional Office for Africa, CDS/80.1.
22. 22. World Health Organization. Recommendations for management of viral haemorrhagic fevers in Africa. In: Workshop on viral haemorrhagic fevers (Freetown, Sierra Leone, 24 28 June 1985). Geneva: WHO, 1985.
23. 23. World Health Organization. Viral haemorrhagic fever - management of suspected cases. Wkly Epidemiol Rec 1995;70:249-52.
24. 24. Centers for Disease Control and Prevention and World Health Organization. Infection control for viral hemorrhagic fevers in the African health care setting Atlanta: CDC, 1998:1-198.
25. 25. Centers for Disease Control and Prevention. Guidelines for preventing the transmission of Mycobacterium tuberculosis in health-care facilities, 1994. MWWR Morb Mortal Weekly Rep 1994;43(RR-13):1-132.
26. 26. Jaax N, Jahrling P, Geisbert T, et al. Transmission of Ebola virus (Zaire strain) to uninfected control monkeys in a biocontainment laboratory. Lancet 1995;346:1669-71.
27. 27. Jaax NK, Davis KJ, Geisbert TJ. Lethal experimental infection of rhesus monkeys with Ebola-Zaire (Mayinga) virus by the oral and conjunctival route of exposure. Arch Pathol Lab Med 1996; 120:140-55.
28. 28. Roels TH, Bloom AS, Buffington J, et al. Ebola hemorrhagic fever, Kikwit, Democratic Republic of the Congo, 1995: risk factors for patients without a reported exposure. J Infect Dis 1999; 179(suppl 1):S92-7.
29. 29. Peters CJ, Jarling PB, Khan AS. Patients infected with high-hazard viruses: scientific basis for infection control. Arch Virol 1996; 11(suppl): 141-68.
30. 30. Soper FL, Rickard ER, Crawford, PJ. The routine postmortem removal of liver tissue from rapidly fatal fever cases for the discovery of silent yellow fever foci. Am J Hyg 1934; 19:549-66.
31. 31. Saliou P, Breman JG. La surveillance épidemiologique des maladies transmissibles dans les pays tropicaux: les principes et une application pratique pour trois maladies soumises au Règlement Sanitaire International (choléra fièvre jaune et variole). Médecine d'Afrique Noire 1977;24: 93-113.
32. 32. Saliou P, Breman JG. Une mallette pour la surveillance epidémiologique de la variole, du choléra et de la fièvre jaune. Bull Soc Pathol Exot Filiales 1976;69:5, 398-411.
33. 33. Saliou P, Rey JL, Breman JG, Stoeckel PH. Une année d'utilisation en Haute-Volta d'une mallette pour la surveillance du choléra, de la fièvre jaune, et de la variole. Bull Soc Pathol Exot Filiales 1977; 70: 544-52.